Amyloid PET findings in multiple sclerosis are associated with cognitive decline at 18 months.

CONCLUSIONSLower white matter uptake in amyloid PET is associated with cognitive decline and an increase in white matter lesion volume during the follow-up. Our study suggests that 18F-florbetaben may be a useful biomarker in assessing myelin status in MS, understanding MS pathophysiology, and predicting cognitive outcomes.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research